Table 2 Nitric oxide in human autoimmune and chronic inflammatory diseases

Rheumatic diseases

Systemic lupus erythematosus

(263–265)

Vasculitis

(266,267)

Rheumatoid arthritis

(264,268–271)

Osteoarthritis

(186,268,

272–274)

Inflammatory airway disease

Asthma

(177,230,

275–277)

Respiratory tract infections

(278–282)

Idiopathic pulmonary fibrosis

(283–285)

Bronchiectasis

(286–288)

Gastrointestinal system

Inflammatory bowel disease

(289)

Ulcerative colitis

(290–293)

Crohn’s disease

(290–292,294)

Diverticulitis

(290,295)

Necrotizing enterocolitis

(296–298)

Celiac disease

(299–302)

Helicobacter pylori-associated

chronic gastritis

(303–306)

Kidney

Glomerulonephritis

(307–310)

Lupus nephritis

(310–312)

Pancreas

Diabetes

(313–316)

Pancreatitis

(317)

Liver

Chronic hepatitis

(318,319)

Bladder

Infectious and noninfectious

(320–323)

cystitis

Central and peripheral

nervous system

Parkinson’s disease

(324–326)

Multiple sclerosis

(327–330)

Severe AIDS dementia

(331–333)

Vasculitic and optic neuropathy

(334,335)

Skin

(336)

Psoriasis

(337–340)

Cutaneous lupus erythematosus

(341)

Systemic sclerosis

(342–344)

Dermatitis

(345–347)

Atherosclerosis

(219–221,

348–350)

Periapical periodontitis

(351–353)

Sjögren’s syndrome

(354–356)